CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR-T therapy aimed at tough kidney disease in kids — but trial never started
Disease control TerminatedThis was a planned early-stage trial to test whether anti-CD19 CAR-T cells could safely help children with multi-drug resistant nephrotic syndrome, a serious kidney condition. The study was withdrawn before any patients were enrolled, so no data on safety or effectiveness were co…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
CAR-T trial for kids with rare vasculitis withdrawn before starting
Disease control TerminatedThis study planned to test anti-CD19 CAR-T cells in children aged 5-25 with refractory ANCA-associated vasculitis, a rare autoimmune disease. The trial was withdrawn before enrolling any participants, so no results or conclusions are available. CAR-T therapy aims to reset the imm…
Matched conditions: CAR T CELL THERAPY
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Engineered immune cells take on lupus in new safety trial
Disease control OngoingThis early-stage study tests whether a special type of immune cell, called a CAR-T cell, is safe for people with severe lupus that hasn't responded to standard treatments. The cells are designed to target and destroy faulty immune cells that cause lupus. The trial includes 22 chi…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
Real-World data shows promise for CNCT-19 in tough leukemia
Disease control OngoingThis study looks at how well a treatment called CNCT-19 works for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). Researchers will review medical records from 275 patients across multiple hospitals in China to see how many achieve remission an…
Matched conditions: CAR T CELL THERAPY
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC